SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending following news of a strategic manufacturing partnership aimed at significantly reducing production costs and expanding capacity, which has driven substantial intraday stock volatility. The community is actively discussing the stock's low float and high trading volume, fueling speculation about a potential short squeeze and anticipating further upward movement as it tests key resistance levels. This partnership is seen as a crucial step for scaling their fingerprint drug screening technology ahead of anticipated future market expansion.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending due to recent discussions surrounding its integration as a fuel-discount token within the EzFill app, generating buzz about its expanding utility. The community is sharply divided, with many anticipating significant future appreciation from multi-year lows and viewing it as "digital silver," while others express frustration over its recent price action and struggle to overcome key resistance levels.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is currently a focal point for year-end tax loss selling, leading to sharp price movements and a polarized community discussion. Many foresee further declines for the meme coin, while a resilient group of long-term holders views the current dip as a strategic accumulation opportunity for future crypto cycles, with eyes on a potential rally in 2026.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending significantly following the FDA approval of NEREUS, marking the first new pharmacologic treatment for motion-induced vomiting in over four decades. The community is actively discussing the drug's potential beyond motion sickness, particularly its vast opportunity in addressing GLP-1 induced nausea, which many see as a transformative revenue driver for the company. With analysts raising price targets and whispers of potential buyout interest, investors anticipate continued upside as the market fully prices in this key regulatory win and the company's robust pipeline.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp (ESHA) is trending within a volatile low-float SPAC sector, fueled by discussions surrounding its extremely tight share float and high insider ownership. The community is actively debating its potential for rapid price movement and a short squeeze, drawing comparisons to other recently surging SPACs as new utility via a planned reward token is also highlighted.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending with significant volatility after receiving an FDA Complete Response Letter for its relacorilant drug, triggering a sharp decline in shares. The community is fiercely divided, with many calling the sell-off an overreaction given the company's existing profitable drug and deep pipeline, while others foresee further downside following analyst downgrades and a need for more clinical evidence. This binary regulatory event has intensified speculation, as investors weigh potential recovery against lingering uncertainty.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following the FDA's acceptance and priority review of AXS-05 for Alzheimer's disease agitation, alongside positive feedback supporting an upcoming NDA for AXS-12 in narcolepsy. The market is reacting strongly to this dual pipeline advancement, with community members expressing high optimism and noting significant short-covering as a key driver of the momentum.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending after a competitor's drug for Cushing's syndrome received a regulatory setback from the FDA, which the community views as a significant advantage for Xeris's approved treatment, Recorlev. This development is seen as clearing the path for Recorlev to gain market share, fueling discussions among investors about the company's long-term growth potential and undervaluation, supported by positive analyst outlooks.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is highly active following the CME Group's recent, repeated increases in margin requirements for silver futures, sparking intense debate among traders who see it as a desperate measure to control a surging market. This volatility is further fueled by conflicting narratives around impending Chinese silver export restrictions and the growing disconnect between paper and physical prices. The community is sharply divided between those predicting a massive short squeeze driven by industrial demand and global supply shifts, and those anticipating a significant pullback.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

ALCY is attracting considerable attention, primarily driven by its status as a low-float SPAC, leading to strong comparisons with other recent tickers that have seen significant, swift price movements. The community is actively discussing "dip buys" and speculating on potential upside, with many anticipating a continuation of the "low float SPAC bubble" trend while also acknowledging the inherent risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Apple (AAPL) fell 0.3% on Thursday after the company reportedly won a partial reversal of parts of a court order requiring the company to make changes to its App Store to promote greater competition in a long-running lawsuit brought by 'Fortnite' creator Epic Games.Apple filed a notice of appeal in May after U.S. District Judge Yvonne Gonzalez Rogers ruled that Apple willfully violated a 2021 injunction that allowed developers to direct users to alternative, non-Apple payment options.In her ruling, Gonzalez Rogers criticized Apple for creating new obstacles — including a 27% fee for out-of-store purchases — and for deploying so-called “scare screens” that discouraged consumers from using third-party payment systems.<h2 class="st-heading-2">Partial Reversal Terms</h2>Reuters<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/sustainability/boards-policy-regulation/us-appeals-court-partly-reverses-sanctions-against-apple-epic-games-antitrust-2025-12-11/"> reported</a> on Thursday that the San Francisco-based 9th U.S. Circuit Court of Appeals ruled that parts of the judge’s April order holding Apple in contempt for violating a prior decision were overbroad and must be modified. However, the appeals court upheld most of the contempt filing and the company lost its bid to overturn the injunction, the report added.The court altered part of the lower court's ruling that barred Apple from charging any commission or fee tied to purchases that do not take place on the Apple platform and said the trial judge must now modify that part of her order.<h2 class="st-heading-2">The Long Legal Battle</h2>The tech giant and Epic Games have been at odds since 2020, when the latter alleged that the iPhone maker’s practice of charging a 30% commission on in-app payments violated U.S. antitrust laws. While Apple mostly won the lawsuit, it was still required to allow developers to include links in their apps directing users to alternative purchasing methods.Apple subsequently imposed a 27% commission on developers for purchases made outside the App Store and Epic Games returned to court, complaining that the 27% commission is in violation of the injunction, leading up to Gonzalez Rogers’ ruling and the subsequent appeal.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around AAPL stayed within the ‘neutral’ territory over the past 24 hours, while message volume remained at ‘normal’ levels.<a href="https://stocktwits.com/symbol/AAPL">AAPL stock</a> has gained 11% this year and by about 13% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/rhythm-pharmaceuticals-stock-rises-after-positive-study-data-for-setmelanotide-in-treating-genetic-disorder/cLIxj7cREFG">Rhythm Pharmaceuticals Stock Rises After Positive Study Data For Setmelanotide In Treating Genetic Disorder</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

The Apple logo displays on a screen with a person holding a phone in Knurow, Poland, on September 20, 2025. 

Apple Scores Partial Win In Epic Games Fight As Appeals Court Scales Back Parts of Sanctions: Report

 The San Francisco-based 9th U.S. Circuit Court of Appeals reportedly ruled that parts of a judge’s April order holding Apple in contempt for violating a prior decision were overbroad and must be modified.

Equity

 The San Francisco-based 9th U.S. Circuit Court of Appeals reportedly ruled that parts of a judge’s April order holding Apple in contempt for violating a prior decision were overbroad and must be modified.


The Federal Trade Commission (FTC) said it would send&nbsp;more than $126 million in refunds to Fortnite gamers as compensation for the unwanted purchases they were forced to make due to the video game maker’s deceptive practices.The proposed payout is part of the $245 million settlement agreement reached between Fortnite developer <a href="https://stocktwits.com/symbol/EPIC">Epic Games</a> and the FTC&nbsp;in 2023.&nbsp;The first tranche of 629,344 payments, amounting to more than $72 million, was sent out in December 2024.&nbsp;The next batch of payments will go to those who filed a claim after Feb. 14, 2025.Also, the federal agency said it was reopening the process for Fortnite gamers and their parents or guardians, who have not yet submitted a compensation claim. The aggrieved parties now have until July 9 to submit a claim at&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="http://www.ftc.gov/fortnite">www.ftc.gov/fortnite</a>.&nbsp;Those eligible for receiving the payment included those who were charged in-game currency for items between&nbsp;January 2017 and&nbsp;September 2022, those whose children made charges to their credit&nbsp;cards without their knowledge between Jan. 2017 and Nov. 2018, and those whose accounts were locked between Jan. 2017 and Sept. 2022 after they complained to their credit card company about wrongful charges.&nbsp;A claimant should be&nbsp;at least 18 years&nbsp;old to be&nbsp;eligible for a refund.&nbsp;The FTC will send 969,173 checks and PayPal payments on June 25-26 to consumers who have filed a valid claim.With the payment announced on Wednesday, the total refunds by the FTC related to Epic’s deceptive billing practices work out to nearly $200 million.The FTC issued directives to the claimants and said consumers would choose the payment mode when submitting the claim. Those receiving the checks should encash them within 90 days, and those who opted for PayPal payments should redeem them within 30 days.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ai-driven-demand-powers-micron-s-q3-outperformance/chmOe0ORREt">‘AI-Driven Memory Demand’ Powers Micron’s Q3 Outperformance: Stock Shows Muted Gains, But Retail Optimism Grows</a>

Fairgoers play video games at the Japanese publisher Nintendo Switch's stand during Milan Games Week & Cartoomics 2024 at Fiera Milano Rho on November 22, 2024 in Milan, Italy. 

Did Fortnite Trick You Into Spending? FTC Starts Sending Out $126M In Refunds

The proposed payout is part of the $245 million settlement agreement between Fortnite and the FTC from two years ago. 

EPIC
Epic Games

Latest EPIC News

EPICEpic Games

Latest EPIC News

EPIC
Epic Games